Tag: Proactive

Posted on

iSonea rapidly approaches commercialisation, targets US$16 billion asthma market – Proactive Investors USA & Canada


mobihealthnews

iSonea rapidly approaches commercialisation, targets US$16 billion asthma market
Proactive Investors USA & Canada
iSonea (ASX: ISN) is preparing to roll out a number of its asthma products over the next 24 months after entering its first formal partnership with telecommunications company Qualcomm Life for the development of a mobile asthma monitoring platform.
iSonea to Develop New Asthma Mobile Health Technology Based on Qualcomm 2net HubEON: Enhanced Online News (press release)
Qualcomm Life, iSonea to offer mobile asthma monitormobihealthnews
iSonea gains partner to develop new mobile asthma monitoring systemProactive Investors UK

all 16 news articles »

View full post on asthma – Google News

Posted on

iSonea rapidly approaches commercialisation, targets US$16 billion asthma market – Proactive Investors UK


mobihealthnews

iSonea rapidly approaches commercialisation, targets US$16 billion asthma market
Proactive Investors UK
iSonea (ASX: ISN) is preparing to roll out a number of its asthma products over the next 24 months after entering its first formal partnership with telecommunications company Qualcomm Life for the development of a mobile asthma monitoring platform.
iSonea to Develop New Asthma Mobile Health Technology Based on Qualcomm 2net HubMarketWatch (press release)
Qualcomm Life, iSonea to offer mobile asthma monitormobihealthnews
iSonea gains partner to develop new mobile asthma monitoring systemProactive Investors USA & Canada

all 15 news articles »

View full post on asthma – Google News

Posted on

iSonea gains partner to develop new mobile asthma monitoring system – Proactive Investors Australia

iSonea gains partner to develop new mobile asthma monitoring system
Proactive Investors Australia
They are focused on pulmonary acoustics as diagnostic and monitoring tools for managing asthma. iSonea is a step closer to achieving a core objective of its commercialisation plan of developing over-the-counter asthma monitoring devices with mobile …

View full post on asthma – Google News

Posted on

iSonea launches into US market with American Depositary Receipts – Proactive Investors Australia


Proactive Investors Australia

iSonea launches into US market with American Depositary Receipts
Proactive Investors Australia
Medical technology company iSonea is focused on developing innovative monitoring systems and software for the management of asthma. The company is currently working on the development and launch of the first Acoustic Respiratory Monitoring devices, …
iSonea rights issues provides better than expected return of A$4.6mProactive Investors USA & Canada

all 4 news articles »

View full post on asthma – Google News

Posted on

iSonea accelerates commercialisation of asthma devices in US, in negotiations … – Proactive Investors Australia

iSonea accelerates commercialisation of asthma devices in US, in negotiations …
Proactive Investors Australia
They are focused on pulmonary acoustics as diagnostic and monitoring tools for managing asthma. iSonea is currently in negotiations with major strategic partners to accelerate commercialisation and cash flows of its next generation asthma products in …

View full post on asthma – Google News

Posted on

AstraZeneca, Dynavax amend agreement to accelerate development of asthma drug – Proactive Investors USA & Canada


Proactive Investors USA & Canada

AstraZeneca, Dynavax amend agreement to accelerate development of asthma drug
Proactive Investors USA & Canada
AstraZeneca (NYSE:AZN) and Dynavax Technologies (NASDAQ:DVAX) announced Wednesday they have amended their collaboration agreement so as to accelerate the development of AZD1419, intended for the treatment of asthma. Under the terms of the agreement, …
Dynavax and AstraZeneca to Advance TLR-9 Agonist Into Clinic for AsthmaMarketWatch (press release)
Dynavax gets $3M in reworked asthma deal with AstraZenecaBizjournals.com (blog)

all 12 news articles »

View full post on asthma – Google News

Posted on

KarmelSonix appoints Viriathus to support OTC listing, to step up U.S. asthma … – Proactive Investors Australia


Proactive Investors Australia

KarmelSonix appoints Viriathus to support OTC listing, to step up U.S. asthma …
Proactive Investors Australia
KarmelSonix focuses on supplying innovative, non-invasive acoustic tools for disease management of asthma and related pulmonary disorders. The company's product offerings afford KarmelSonix a unique opportunity to adopt a business model that combines …

View full post on asthma – Google News